共 90 条
[1]
Bauer LA(1996)Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations Ther Drug Monit 18 46-52
[2]
Horn JR(2009)Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study Eur J Clin Pharmacol 65 1237-1243
[3]
Pettit H(2007)Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration Pharmacotherapy 27 472-475
[4]
Chan AL(2002)Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization Am J Ther 9 492-498
[5]
Wang MT(2011)Calcium channel blockers J Clin Hypertens (Greenwich) 13 687-689
[6]
Su CY(2011)Potentially harmful drug–drug interactions in the elderly: a review Am J Geriatr Pharmacother 9 364-377
[7]
Tsai FH(2003)Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the digitalis in acute atrial fibrillation trial Eur J Clin Pharmacol 58 747-755
[8]
DeVore KJ(1993)The importance of modeling interoccasion variability in population pharmacokinetic analyses J Pharmacokinet Biopharm 21 735-750
[9]
Hobbs RA(1977)Bioavailability of digoxin: some pitfalls and problems Int J Clin Pharmacol Biopharm 15 549-556
[10]
EL Desoky ES(1992)Changes in the plasma levels and basic pharmacokinetic parameters of digoxin used in combination with gentamicin, amiodarone and spironolactone Folia Med (Plovdiv) 34 24-28